Skip to main content
. 2022 Dec 13;31(1):1. doi: 10.1007/s00520-022-07456-x

Fig. 1.

Fig. 1

Overview of the ALL-11 treatment protocol and the four study assessments. Medium risk patients were given a fifth assessment (T1.5) during treatment with dexamethasone